605 related articles for article (PubMed ID: 27893843)
1. Comparative Effectiveness of Smoking Cessation Medications: A National Prospective Cohort From Taiwan.
Chang PY; Lo PC; Chang HC; Hsueh KC; Tsai YW
PLoS One; 2016; 11(11):e0166992. PubMed ID: 27893843
[TBL] [Abstract][Full Text] [Related]
2. Comparative Effectiveness of Varenicline and Nicotine Replacement Therapy for Smoking Cessation in Older and Younger Smokers: A Prospective Cohort in Taiwan.
Chang PY; Shiu MN; Yuan YT; Chang HC; Su PY; Lan TH
Nicotine Tob Res; 2019 Jan; 21(2):149-155. PubMed ID: 29294121
[TBL] [Abstract][Full Text] [Related]
3. Flexible, dual-form nicotine replacement therapy or varenicline in comparison with nicotine patch for smoking cessation: a randomized controlled trial.
Tulloch HE; Pipe AL; Els C; Clyde MJ; Reid RD
BMC Med; 2016 Jun; 14():80. PubMed ID: 27233840
[TBL] [Abstract][Full Text] [Related]
4. Effects of Nicotine Patch vs Varenicline vs Combination Nicotine Replacement Therapy on Smoking Cessation at 26 Weeks: A Randomized Clinical Trial.
Baker TB; Piper ME; Stein JH; Smith SS; Bolt DM; Fraser DL; Fiore MC
JAMA; 2016 Jan; 315(4):371-9. PubMed ID: 26813210
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the effectiveness of varenicline and transdermal nicotine patch in outpatients following a standardized smoking cessation program in Southern Taiwan.
Hsueh SC; Hsueh KC; Chou MY; Tu MS
Eval Health Prof; 2015 Mar; 38(1):115-25. PubMed ID: 23221355
[TBL] [Abstract][Full Text] [Related]
6. Varenicline versus nicotine patch with brief advice for smokers with substance use disorders with or without depression: effects on smoking, substance use and depressive symptoms.
Rohsenow DJ; Tidey JW; Martin RA; Colby SM; Swift RM; Leggio L; Monti PM
Addiction; 2017 Oct; 112(10):1808-1820. PubMed ID: 28498504
[TBL] [Abstract][Full Text] [Related]
7. An internet survey of use, opinions and preferences for smoking cessation medications: nicotine, varenicline, and bupropion.
Etter JF; Schneider NG
Nicotine Tob Res; 2013 Jan; 15(1):59-68. PubMed ID: 22529220
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of COPD smokers and effectiveness and safety of smoking cessation medications.
Jiménez Ruiz CA; Ramos Pinedo A; Cicero Guerrero A; Mayayo Ulibarri M; Cristobal Fernández M; Lopez Gonzalez G
Nicotine Tob Res; 2012 Sep; 14(9):1035-9. PubMed ID: 22345320
[TBL] [Abstract][Full Text] [Related]
9. Moderators of real-world effectiveness of smoking cessation aids: a population study.
Jackson SE; Kotz D; West R; Brown J
Addiction; 2019 Sep; 114(9):1627-1638. PubMed ID: 31117151
[TBL] [Abstract][Full Text] [Related]
10. Real-life effectiveness of smoking-cessation treatments in general practice clinics in Denmark. The Escape Smoke project.
Poulsen PB; Spillemose H; Nielsen G; Hergel LL; Wedell-Wedellsborg D; Strand M; Ringbæk T
Respir Med; 2015 Feb; 109(2):218-27. PubMed ID: 25592244
[TBL] [Abstract][Full Text] [Related]
11. Abstinence and psychological distress in co-morbid smokers using various pharmacotherapies.
Steinberg MB; Bover MT; Richardson DL; Schmelzer AC; Williams JM; Foulds J
Drug Alcohol Depend; 2011 Mar; 114(1):77-81. PubMed ID: 20951511
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of varenicline combined with nicotine replacement therapy vs varenicline alone for smoking cessation: a randomized clinical trial.
Koegelenberg CF; Noor F; Bateman ED; van Zyl-Smit RN; Bruning A; O'Brien JA; Smith C; Abdool-Gaffar MS; Emanuel S; Esterhuizen TM; Irusen EM
JAMA; 2014 Jul; 312(2):155-61. PubMed ID: 25005652
[TBL] [Abstract][Full Text] [Related]
13. Real-World Effectiveness of Pharmaceutical Smoking Cessation Aids: Time-Varying Effects.
Chaiton M; Diemert LM; Bondy SJ; Cohen JE; Fung MD; Zhang BR; Ferrence RG
Nicotine Tob Res; 2020 Apr; 22(4):506-511. PubMed ID: 30260455
[TBL] [Abstract][Full Text] [Related]
14. Comparative effects of varenicline or combination nicotine replacement therapy versus patch monotherapy on candidate mediators of early abstinence in a smoking cessation attempt.
Kim N; McCarthy DE; Piper ME; Baker TB
Addiction; 2021 Apr; 116(4):926-935. PubMed ID: 32888230
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in Greece.
Athanasakis K; Igoumenidis M; Karampli E; Vitsou E; Sykara G; Kyriopoulos J
Clin Ther; 2012 Aug; 34(8):1803-14. PubMed ID: 22818870
[TBL] [Abstract][Full Text] [Related]
16. An exploratory short-term double-blind randomized trial of varenicline versus nicotine patch for smoking cessation in women.
Gray KM; McClure EA; Baker NL; Hartwell KJ; Carpenter MJ; Saladin ME
Addiction; 2015 Jun; 110(6):1027-34. PubMed ID: 25727442
[TBL] [Abstract][Full Text] [Related]
17. Quitting Failure and Success With and Without Using Medication: Latent Classes of Abstinence and Adherence to Nicotine Monotherapy, Combination Therapy, and Varenicline.
McCarthy DE; Versella MV
Nicotine Tob Res; 2019 Oct; 21(11):1488-1495. PubMed ID: 30107419
[TBL] [Abstract][Full Text] [Related]
18. Varenicline versus transdermal nicotine patch: a 3-year follow-up in a smoking cessation clinic in Taiwan.
Hsueh KC; Hsueh SC; Chou MY; Pan LF; Tu MS; McEwen A; West R
Psychopharmacology (Berl); 2014 Jul; 231(14):2819-23. PubMed ID: 24522334
[TBL] [Abstract][Full Text] [Related]
19. Neuropsychiatric Safety and Efficacy of Varenicline, Bupropion, and Nicotine Patch in Smokers With Psychotic, Anxiety, and Mood Disorders in the EAGLES Trial.
Evins AE; Benowitz NL; West R; Russ C; McRae T; Lawrence D; Krishen A; St Aubin L; Maravic MC; Anthenelli RM
J Clin Psychopharmacol; 2019; 39(2):108-116. PubMed ID: 30811371
[TBL] [Abstract][Full Text] [Related]
20. Diminishing benefit of smoking cessation medications during the first year: a meta-analysis of randomized controlled trials.
Rosen LJ; Galili T; Kott J; Goodman M; Freedman LS
Addiction; 2018 May; 113(5):805-816. PubMed ID: 29377409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
